Literature DB >> 27118568

Carbachol-induced signaling through Thr696-phosphorylation of myosin phosphatase-targeting subunit 1 (MYPT1) in rat bladder smooth muscle cells.

Benchun Liu1, Yung-Chin Lee1,2, Amjad Alwaal1, Guifang Wang1, Lia Banie1, Ching-Shwun Lin1, Guiting Lin1, Tom F Lue3.   

Abstract

PURPOSE: Lines of evidence suggest that Rho-associated protein kinase (ROCK)-mediated myosin phosphatase-targeting subunit 1 (MYPT1) phosphorylation plays a central role in smooth muscle contraction. However, the physiological significance of MYPT1 phosphorylation at Thr696 catalyzed by ROCK in bladder smooth muscle remains controversial. We attempt to directly observe the quantitative protein expression of Rho A/ROCK and phosphorylation of MYPT1 at Thr696 after carbachol administration in rat bladder smooth muscle cells (RBMSCs).
MATERIALS AND METHODS: Primary cultured smooth muscle cells were obtained from rat bladders. The effects of both concentration and time-course induced by the muscarinic agonist carbachol were investigated by assessing the expression of Rho A/ROCK and MYPT1 phosphorylation at Thr696 using Western blot.
RESULTS: In the dose-course studies, carbachol showed significant increase in phosphorylation of MYPT1 at Thr696 (p-MYPT1) from concentrations of 15-100 μM based on Western blot results (p < 0.05, ANOVA test). In the time-course studies, treatment of cells with 15 μM of carbachol significantly enhanced the expression of p-MYPT1 from 3 to 15 h (p < 0.05, ANOVA test) and induced the expression of Rho A from 10 to 120 min (p < 0.05, ANOVA test).
CONCLUSIONS: Carbachol can induce the expression of ROCK pathway, leading to MYPT1 phosphorylation at Thr696 and thereby sustained RBSMCs contraction.

Entities:  

Keywords:  Bladder smooth muscle cell; Carbachol; Phosphorylation; Rat; Rho-associated protein kinase (ROCK)

Mesh:

Substances:

Year:  2016        PMID: 27118568      PMCID: PMC4955765          DOI: 10.1007/s11255-016-1303-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  31 in total

Review 1.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

2.  Bladder smooth muscle organ culture preparation maintains the contractile phenotype.

Authors:  Tanchun Wang; Derek M Kendig; Shaohua Chang; Danielle M Trappanese; Samuel Chacko; Robert S Moreland
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-15

3.  Myosin phosphatase target subunit 1 (MYPT1) regulates the contraction and relaxation of vascular smooth muscle and maintains blood pressure.

Authors:  Yan-Ning Qiao; Wei-Qi He; Cai-Ping Chen; Cheng-Hai Zhang; Wei Zhao; Pei Wang; Lin Zhang; Yan-Ze Wu; Xiao Yang; Ya-Jing Peng; Ji-Min Gao; Kristine E Kamm; James T Stull; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

4.  Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase.

Authors:  Andrea Murányi; Justin A MacDonald; Jing Ti Deng; David P Wilson; Timothy A J Haystead; Michael P Walsh; Ferenc Erdodi; Eniko Kiss; Yue Wu; David J Hartshorne
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

5.  Comparison of lower urinary tract symptoms between women with detrusor overactivity and impaired contractility, and detrusor overactivity and preserved contractility.

Authors:  Kobi Stav; Yaniv Shilo; Amnon Zisman; Arie Lindner; Dan Leibovici
Journal:  J Urol       Date:  2012-12-05       Impact factor: 7.450

6.  Ca2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response.

Authors:  Rosalyn P Johnson; Ahmed F El-Yazbi; Kosuke Takeya; Emma J Walsh; Michael P Walsh; William C Cole
Journal:  J Physiol       Date:  2009-04-09       Impact factor: 5.182

7.  Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction.

Authors:  Alexander Khromov; Nandini Choudhury; Andra S Stevenson; Avril V Somlyo; Masumi Eto
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

8.  Phosphorylation of CPI17 and myosin binding subunit of type 1 protein phosphatase by p21-activated kinase.

Authors:  Norio Takizawa; Yasuhiko Koga; Mitsuo Ikebe
Journal:  Biochem Biophys Res Commun       Date:  2002-10-04       Impact factor: 3.575

9.  Signaling through myosin light chain kinase in smooth muscles.

Authors:  Ning Gao; Jian Huang; Weiqi He; Minsheng Zhu; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

10.  Reconstituted human myosin light chain phosphatase reveals distinct roles of two inhibitory phosphorylation sites of the regulatory subunit, MYPT1.

Authors:  Mukta Khasnis; Akiko Nakatomi; Kristyn Gumpper; Masumi Eto
Journal:  Biochemistry       Date:  2014-04-18       Impact factor: 3.162

View more
  3 in total

1.  cAMP-dependent regulation of RhoA/Rho-kinase attenuates detrusor overactivity in a novel mouse experimental model.

Authors:  William Akakpo; Biljana Musicki; Arthur L Burnett
Journal:  BJU Int       Date:  2017-04-11       Impact factor: 5.588

2.  Carvedilol alleviates lipopolysaccharide (LPS)-induced acute lung injury by inhibiting Ras homolog family member A (RhoA)/ROCK activities.

Authors:  Jing Xu; Shipin Zhao; Li Zhao; Mengxiu Sun
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

3.  Effect of Electroacupuncture on Bladder Dysfunction via Regulation of MLC and MLCK Phosphorylation in a Rat Model of Type 2 Diabetes Mellitus.

Authors:  Xuke Han; Yang Gao; Xuan Yin; Shengju Wang; Xiaoran Zhang; Qiu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.